1. Addor FA, Aoki V. Skin barrier in atopic dermatitis. An Bras Dermatol. 2010;85(2):184-94.

2. Katayama I, Aihara M, Ohya Y, Saeki H, Shimojo N, Shoji S, Taniguchi M, YamadaH; Japanese Society of Allergology. Japanese guidelines for atopic dermatitis 2017. Allergol Int. 2017;66(2):230-47.

3. Gonzalez ME, Schaffer JV, Orlow SJ, Gao Z, Li H, Alekseyenko AV, et al. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis. J Am Acad Dermatol. 2016;75(3):481-93.

4. Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med. 2005;352(22):2314-24.

5. Furue M, Chiba T, Tsuji G, Ulzii D, Kido-Nakahara M, Nakahara T, et al. Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies. Allergol Int. 2017;S1323- 8930(16)30171-X.

6. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. 2004;113(5):832-6.

7. Osawa R, Akiyama M, Shimizu H. Filaggrin gene defects and the risk of developing allergic disorders. Allergol Int. 2011;60(1):1-9.

8. Deckers IA, McLean S, Linssen S, Mommers M, van Schayck CP, Sheikh A. Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies. PLoS One 2012;7:e39803.

9. Williams H, Stewart A, von Mutius E, Cookson W, Anderson HR, and the International Study of Asthma and Allergies in Childhood (ISAAC) Phase One and Three Study Groups. Is eczema really on the increase worldwide? J Allergy Clin Immunol. 2008;121:947‑54.

10. Ballardini N, Kull I, Soderhall C, Lilja G, Wickman M, Wahlgren CF. Eczema severity in preadolescent children and its relation to sex, filaggrin mutations, asthma, rhinitis, aggravating factors and topical treatment: a report from the BAMSE birth cohort. Br J Dermatol. 2013;168:588-94.

11. Illi S, von Mutius E, Lau S, Nickel R, Grüber C, Niggemann B, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol. 2004;113:925‑31.

12. Peters AS, Kellberger J, Vogelberg C, Dressel H, Windstetter D, Weinmayr G, et al. Prediction of the incidence, recurrence, and persistence of atopic dermatitis in adolescence: a prospective cohort study. J Allergy Clin Immunol. 2010;126:590-95.

13. Draaisma E, Garcia-Marcos L, Mallol J, Solé D, Pérez-Fernández V, Brand PL, et al. A multinational study to compare prevalence of atopic dermatitis in the first year of life. Pediatr Allergy Immunol. 2015;26(4):359-66.

14. Solé D, Rosário Filho NA, Sarinho ES, Camelo-Nunes IC, Paes Barreto BA, Medeiros ML, et al. Prevalence of asthma and allergic diseases in adolescents: nine-year follow-up study (2003-2012). J Pediatr (Rio J). 2015;91(1):30-35.

15. Silverberg JI, Hanifin JM. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Allergy Clin Immunol. 2013;132:1132‑38.

16. Margolis JS, Abuabara K, Bilker W, Hoffstad O, Margolis DJ. Persistence of mild to moderate atopic dermatitis. JAMA Dermatol. 2014;150:593-600.

17. Weidinger S, Gupta AK. Atopic dermatitis. Lancet. 2016;387(10023):1109-22.

18. Wandalsen GF, Camelo-Nunes ICC, Naspitz CK, Solé D. Fatores de risco para eczema atópico em escolares. Rev Inst Matern Infant Pernamb. 2005;5:19-25.

19. Kantor R, Silverberg JI. Environmental risk factors and their role in the management of atopic dermatitis. Exp Rev Clin Immunol. 2017:13(1):15-20.

20. Andersson NW, Hansen M V, Larsen AD, Hougaard KS, Kolstad HA, Schlünssen V. Prenatal maternal stress and atopic diseases in the child: a systematic review of observational human studies. Allergy. 2016:71:15-26.

21. Kantor R, Kim A, Thyssen J, Silverberg JI. Association of atopic dermatitis with smoking: A systematic review and meta-analysis. J Am Acad Dermatol. 2016:75(6):1119-25.

22. Shaheen SO, Rutterford C, Zuccolo L, Ring SM, Davey Smith G, Holloway JW, et al. Prenatal alcohol exposure and childhood atopic disease: a Mendelian randomization approach. J Allergy Clin Immunol. 2014:133:225-32.

23. Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol. 2009:129:1892-908.

24. Sole D, Camelo-Nunes IC, Wandalsen GF, Mallozi MC, Naspitz CK; Brazilian ISAAC Group. Prevalence of atopic eczema and related symptoms in Brazilian schoolchildren: results from the International Study of Asthma and Allergies in Childhood (ISAAC) phase 3. J Investig Allergol Clin Immunol. 2006:16:367-76.

25. Silverberg JI, Hanifin J, Simpson EL. Climatic factors are associated with childhood eczema prevalence in the United States. J Invest Dermatol. 2013;33:1752-9.

26. Ahn K. The role of air pollutants in atopic dermatitis. J Allergy Clin Immunol. 2014;134:993-9.

27. Morgenstern V, Zutavern A, Cyrys J, Brockow I, Koletzko S, Krämer U, et al. Atopic diseases, allergic sensitization, and exposure to traffic-related air pollution in children. Am J Respir Crit Care Med. 2008;177:1331-7.

28. Song S, Lee K, Lee YM, Lee JH, Lee SI, Yu SD, et al. Acute health effects of urban fine and ultrafine particles on children with atopic dermatitis. Environ Res. 2011;111:394-9.

29. Bornehag CG, Sundell J, Hagerhed-Engman L, Sigsggard T, Janson S, Aberg N, et al. Association between ventilation rates in

390 Swedish homes and allergic symptoms in children. Indoor Air. 2005;15:275-80.

30. Engebretsen KA, Bager P, Wohlfahrt J, Skov L, Zachariae C, Andersen CAN, et al. Prevalence of atopic dermatitis in infants by domestic water hardness and 1 season of birth. J Allergy Clin Immunol. 2016 Dec 23. pii: S0091-6749(16)32464-2.

31. Thomas KS, Dean T, O'Leary C, Sach TH, Koller K, Frost A, et al. A randomised controlled trial of ion-exchange water softeners for the treatment of eczema in children. PLoS Med. 2011;8: e1000395.

32. Kramer M S, Kakuma R. Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child. Evid Based Child Health. 2014:9:447-83.

33. Alm B, Aberg N, Erdes L, Möllborg P, Pettersson R, Norvenius SG, et al. Early introduction of fish decreases the risk of eczema in infants. Arch Dis Child. 2009;94:11-15.

34. Ellwood P, Asher M I, Garcia-Marcos L, Williams H, Keil U, Robertson C, et al. Do fast foods cause asthma, rhinoconjunctivitis and eczema? Global findings from the International Study of Asthma and Allergies in Childhood (ISAAC) phase three. Thorax. 2013;68:351-60.

35. Saarinen UM, Kajosaari M. Breastfeeding as prophylaxis against atopic disease: prospective follow-up study until 17 years old. Lancet. 1995;346:1065-9.

36. Yang YW, Tsai CL, Lu CY. Exclusive breastfeeding and incident atopic dermatitis in childhood: a systematic review and meta-analysis of prospective cohort studies. Br J Dermatol. 2009;161:373-83.

37. Pelucchi C, Chatenoud L, Turati F, Pelucchi C, Chatenoud L, Turati F, et al. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology. 2012;23:402-14.

38. Boyle RJ, Bath-Hextall FJ, Leonardi-Bee J, Murrell DF, Tang ML. Probiotics for the treatment of eczema: a systematic review. Clin Exp Allergy. 2009;39:1117-27.

39. Spergell JM, Paller AS. Atopic dermatitis and the atopic march. J. Allergy Clin Immunol. 2003;112:118-27.

40. Thomsen SF. Epidemiology and natural history of atopic diseases. Eur Clin Respir J. 2015 Mar 24;2. doi: 10.3402/ecrj.v2.24642.

41. Singh AM, Moore PE, Gern JE, Lemanske RF Jr, Hartert TV. Bronchiolitis to asthma: a review and call for studies of genevirus interactions in asthma causation. Am J Respir Crit Care Med. 2007;175:10819.

42. Ben-Gashir MA. Predictors of atopic dermatitis severity over time J Am Acad Dermatol. 2004;50:349-56.

43. Alduraywish AS, Standl M, Lodge CJ, Abramson MJ, Allen KJ, Erbas B, et al. Is there a march from early food sensitization to later childhood allergic airway disease? Results from two prospective birth cohort studies. Pediatr Allergy Immunol. 2017;28(1):30-7.

44. van Beijsterveldt CE, Boomsma DI. Genetics of parentally reported asthma, eczema and rhinitis in 5-year-old twins. Euro Respir J. 2007;29(3):516-21.

45. Strachan DP, Wong HJ, Spector TD. Concordance and interrelationship of atopic diseases and markers of allergic sensitization among adult female twins. J Allergy Clin Immunol. 2001;108(6):901-7.

46. Barnes KC. An update on the genetics of atopic dermatitis: scratching the surface in 2009. J Allergy Clin Immunol. 2010;125(1):16-29.

47. Hoffjan S, Epplen JT. The genetics of atopic dermatitis: recent findings and future options. J Mol Med. 2005; 83:682-92.

48. Bin L, Leung DY. Genetic and epigenetic studies of atopic dermatitis. Allergy Asthma Clin Immunol. 2016 Oct 19;12:52. eCollection 2016 Oct 19.

49. Gao PS, Rafaels NM, Mu D, Hand T, Murray T, Boguniewicz M, et al. Genetic Variants in TSLP are Associated with Atopic Dermatitis and Eczema Herpeticum. J Allergy Clin Immunol. 2010;125(6):1403-7.

50. Sokolowska-Wojdylo M, Glen J, Zablotna M, Rebala K, Trzeciak M, Sikorska M, et al. The frequencies of haplotypes defined by three polymorphisms of the IL-31 gene: -1066, -2057, and IVS2 +

12 in Polish patients with atopic dermatitis. Int J Dermatol. 2015;54(1):62-7.

51. Stemmler S, Parwez Q, Petrasch-Parwez E, Epplen JT, Hoffjan S. Association of variation in the LAMA3 gene, encoding the alphachain of laminin 5, with atopic dermatitis in a German case-control cohort. BMC Dermatol. 2014;14:17.

52. Margolis DJ, Gupta J, Apter AJ, Ganguly T, Hoffstad O, Papadopoulos M, et al. Filaggrin-2 variation is associated with more persistent atopic dermatitis in African American subjects. J Allergy Clin Immunol. 2014;133(3):784-9.

53. Trzeciak M, Wesserling M, Bandurski T, Glen J, Nowicki R, Pawelczyk T. Association of a Single Nucleotide Polymorphism in a Late Cornified Envelope-like Proline-rich 1 Gene (LELP1) with Atopic Dermatitis. Acta Derm Venereol. 2016;96(4):459-63.

54. Heine G, Hoefer N, Franke A, Nöthling U, Schumann RR, Hamann L, et al. Association of vitamin D receptor gene polymorphisms with severe atopic dermatitis in adults. Br J Dermatol. 2013;168(4):855-8.

55. Kilic S, Silan F, Hiz MM, Isik S, Ögretmen Z, Özdemir Ö. Vitamin D receptor gene BSMI, FOKI, APAI, and TAQI polymorphisms and the risk of atopic dermatitis. J Investig Allergol Clin Immunol. 2016;26(2):106-10.

56. Cork MJ, Robinson DA, Vasilopoulos Y, Ferguson A, Moustafa M, MacGowan A, et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol. 2006;118(1):3-21.

57. Hon KL, Leung AK, Barankin B. Barrier repair therapy in atopic dermatitis: an overview. Am J Clin Dermatol. 2013;14(5):389-99.

58. van Smeden J, Bouwstra JA. Stratum corneum lipids: their role for the skin barrier function in healthy subjects and atopic dermatitis patients. Curr Probl Dermatol. 2016;49:8-26.

59. Castro APM, Solé D, Filho NAR, Jacob CMA, Rizzo MCFV, Fernandes MFM, et al. Guia Prático para o Manejo da Dermatite Atópica - opinião conjunta de especialistas em alergologia da Associação Brasileira de Alergia e Imunopatologia e da Sociedade Brasileira de Pediatria. Rev Bras Alerg Imunolpatol. 2006;29(6):268‑82.

60. Draelos ZD. Modern moisturizer myths, misconceptions, and truths. Cutis. 2013;91(6):308-14.

61. Ong PY, Leung DY. Bacterial and Viral Infections in Atopic Dermatitis: aComprehensive Review. Clin Rev Allergy Immunol. 2016;51(3):329‑37.

62. Hepburn L, Hijnen DJ, Sellman BR, Mustelin T, Sleeman MA, May RD, et al. The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies. Br J Dermatol. 2016; Oct 25. doi: 10.1111/bjd.15139. [Epub ahead of print].

63. Dybboe R, Bandier J, Skov L, Engstrand L, Johansen JD. The Role of the Skin Microbiome in Atopic Dermatitis: A Systematic Review. Br J Dermatol. 2017, Feb 16. doi:10.1111/bjd.15390. [Epub ahead of print].

64. Park JM, Jo JH, Jin H, Ko HC, Kim MB, Kim JM, et al. Change in Antimicrobial Susceptibility of Skin-Colonizing Staphylococcus aureus in Korean Patients with Atopic Dermatitis during Ten-Year Period. Ann Dermatol. 2016;28(4):470-8.

65. Leung DY. New Insights into Atopic Dermatitis: Role of Skin Barrier and Immune Dysregulation. Allergol Int. 2013;62:151-61.

66. Boguniewicz M, Leung D. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clinical Immunol. 2010;125(1):4-13.

67. Wang AX, Landén N X. New insights into T cells and their signature cytokines in atopic dermatitis. Int Um Bioc Mol Bio. 2015;67:601‑10.

68. Mrabet-Dahbi S, Maurer M. Does allergy impair innate immunity? Leads and lessons from atopic dermatites. Allergy. 2010;65:1351‑6.

69. Han NR, Oh HA, Nam SY, Moon PD, Kim DW, Kim HM, et al. TSLP induces mast cell development and aggravates allergic reactions through the activation of MDM2 and STAT6. J Invest Dermatol. 2014;134:2521-30.

70. Gutowska-Owsiak D, Schaupp AL, Salimi M, Selvakumar TA, McPherson T, Taylor S, et al. IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion. Exp Dermatol. 2012;21:104-10.

71. Raap U, Weissmantel S, Gehring M, Eisenberg AM, Kapp A, Fölster-Holst R. IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis. Pediatr Allergy Immunol. 2012;23:285-8.

72. Sabat R, Ouyang W, Wolk K. Therapeutic opportunities of the IL22-IL-22R1 system. Nat Rev Drug Discov. 2014;13:21-38.

73. Nakayamada S, Kanno Y, Takahashi H, Jankovic D, Lu KT, Johnson TA, et al. Early Th1 cell differentiation is marked by a Tfh cell-like transition. Immunity. 2011:35:919-31.

74. Sawada E, Yoshida N, Sugiura A, Imokawa G. Th1 cytokines accentuate but Th2 cytokines attenuate ceramide production in the stratum corneum of human epidermal equivalents: an implication for the disrupted barrier mechanism in atopic dermatitis. J Dermatol Sci. 2012;68:25-35.

75. Johnson-Huang LM, Suarez-Farinas M, Pierson KC, FuentesDuculan J, Cueto I, Lentini T, et al. A single intradermal injection of IFN-gamma induces an inflammatory state in both non-lesional psoriatic and healthy skin. J Invest Dermatol. 2012;132:1177‑87.

76. Totte JE, van der Feltz WT, Hennekam M, van Belkum A, van Zuuren EJ, Pasmans SG. Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis. Br J Dermatol. 2016;175(4):687-95.

77. Lubbe J. Secondary infections in patients with atopic dermatitis. Am J Clin Dermatol. 2003;4(9):641-54.

78. Park KD, Pak SC, Park KK. The pathogenic effect of natural and bacterial toxins on atopic dermatitis. Toxins (Basel). 2017;9(1):3.

79. Travers JB. Toxic interaction between Th2 cytokines and Staphylococcus aureus in atopic dermatitis. J Investig Dermatol. 2014;134(8):2069-71.

80. Bunikowski R, Mielke M, Skarabis H, Herz U, Bergmann RL, Wahn U, et al. Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis. J Allergy Clin Immunol. 1999;103(1 Pt 1):119-24.

81. Nomura I, Tanaka K, Tomita H, Katsunuma T, Ohya Y, Ikeda N, et al. Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis. J Allergy Clin Immunol. 1999;104(2 Pt 1):441-6.

82. Zhang X, Shang W, Yuan J, Hu Z, Peng H, Zhu J, et al. Positive feedback cycle of TNF alpha promotes Staphylococcal enterotoxin B-Induced THP-1 cell apoptosis. Frontiers in cellular and infection microbiology. 2016;6:109.

83. Novak N, Bieber T, Leung DY. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol. 2003;112(6 Suppl):S128‑39.

84. Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL, Jr. Skin diseases associated with Malassezia species. J Am Acad Dermatol. 2004;51(5):785-98.

85. Bolognia JL, Jorizzo JL, Rapini RP. Dermatology. Elsevier Health Sciences; 2003.

86. Glatz M, Bosshard PP, Hoetzenecker W, Schmid-Grendelmeier P. The Role of Malassezia spp. in Atopic Dermatitis. J Clin Med. 2015;4(6):1217-28.

87. Aspres N, Anderson C. Malassezia yeasts in the pathogenesis of atopic dermatitis. Austr J Dermatol. 2004;45(4):199-205.

88. Thayikkannu AB, Kindo AJ, Veeraraghavan M. Malassezia-Can it be Ignored? Ind J Dermatol. 2015;60(4):332-9.

89. Mittermann I, Wikberg G, Johansson C, Lupinek C, Lundeberg L, Crameri R, et al. IgE sensitization profiles differ between adult patients with severe and moderate atopic dermatitis. PloS one. 2016;11(5):e0156077.

90. Sampson HA. The evaluation and management of food allergy in atopic dermatitis. Clin Dermatol. 2003;21:183-928.

91. Chiu CY, Huang YL, Tsai MH, Tu YL, Hua MC, Yao TC, et al. Sensitization to food and inhalant allergens in relation to atopic diseases in early childhood: a birth cohort study. PLoS One. 2014 Jul 17;9(7):e102809.

92. Heratizader A, Wichmann K, Werfel T. Food allergy and atopic dermatitis: how are they connected? Cur Allergy Asthma Rep. 2011:11(4):284-91.

93. Boyce JA, Assa'a A, Burks AW, Jones SM, Sampson HA, Wood RA, et AL. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID sponsored expert panel. Nutr Res. 2011;31(1):61-75.

94. Cocco RR. Alergias alimentares. Rev Bras Med. 2012;69:1-5.

95. Werfel T, Heratizadeh A, Niebuhr M, Kapp A, Roesner LM, Karch A, et al. Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber. J Allergy Clin Immunol. 2015;136:96-103,e109.

96. Darsow U, Vieluf D, Ring J. Evaluating the relevance of aeroallergen sensitization in atopic eczema using the tool ‘atopy patch test’: a randomized, double-blind multicenter study. Atopy patch test study group. J Am Acad Dermatol. 1999;40:187-93.

97. Herbarth O, Fritz GJ, Rehwagen M, Richter M, Röder S, Schlink U. Association between indoor renovation activities and eczema in early childhood. Int J Hyg Environ Health. 2006;209:241-7.

98. Scalabrin DM, Bavbek S, Perzanowski MS, Wilson BB, Platts-Mills TA, Wheatley LM. Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and nonasthmatic control subjects. J Allergy Clin Immunol. 1999;104:1273-9.

99. Guillet G, Guillet MH. Natural history of sensitizations in atopic dermatitis. A 3-year follow-up in 250 children: food allergy and high risk of respiratory symptoms. Arch Dermatol. 1992;128:187-92.

100. Kutlua A, Karabacak E, Aydinc E, Ozturka S, Taskapan O, Aydinoz S, et al. Relationship between skin prick and atopic patch test reactivity to aeroallergens and disease severity in children with atopic dermatites. Allergol Immunopathol (Madr). 2013;41(6):369‑73.

101. Wisniewski J, Agrawal R, Minnicozzi S, Xin W, Patrie J, Heymann PW, et al. Sensitization to Food and Inhalant Allergens in Relation to Age and Wheeze Among Children with Atopic Dermatitis. Clin Exp Allergy. 2013;43(10):1160‑70.

102. Wollenberg A, Oranje A, Deleuran M, Simon D, Szalai Z, Kunz B, et al. ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients. J Eur Acad Dermatol Venereol. 2016;30:729-47.

103. Cipriani F, Ricci G, Leoni MC, Capra L, Baviera G, Longo G, et al. Autoimmunity in atopic dermatitis: Biomarker or simply epiphenomenon? J Dermatol. 2014;41:1-8.

104. Valenta R, Natter S, Seiberler S, Wichlas S, Maurer D, Hess M, et al. Molecular characterization of an autoallergen, hom s 1, identified by serum IgE from atopic dermatitis patients. J Invest Dermatol. 1998;111:1178-83.

105. Valenta R, Mittermann I, Werfel T, Garn H, Renz H. Linking allergy to autoimmune disease. Trends Immunol. 2009;30(3):109-16.

106. Honeyman JF. Psychoneuroimmunology and the Skin. Acta Derm Venereol. 2016;96(217):38-46.

107. Gaspar NK, Aide MK. Atopic dermatitis: allergic dermatitis or neuroimmune dermatitis? An Bras Dermatol. 2016;91(4):479‑88.

108. Paller AS, Mancini AJ. Hurwitz Clinical Pediatric Dermatology: A textbook of skin disorders of childhood and adolescence.Elsevier Health Sciences; 2015.

109. Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. Journal of the American Academy of Dermatology. 2014;70(2):338-51.

110. Griffiths C, Barker J, Bleiker T, Chalmers R, Creamer D. Rook's Textbook of Dermatology, 4 Volume. Set: Wiley; 2016.

111. Pires MC, Cestari S. In: Dermatite atópica. Rio de Janeiro: Ed. Diagraphic; 2005. p. 111-8.

112. Pires MC, Santos RNR. Dermatites e eczemas. In: Sittart JAS & Pires MC. Dermatologia na prática médica. São Paulo: Ed. Roca; 2007. p. 31-62.

113. Ezzedine K, Droitcourt C, Ged C, Diallo A, Hubiche T, de Verneuil H, et al. Usefulness of a global clinical icthyosis vulgaris scoring system for predicting common FLG null mutations in an adult caucasian populations. Br J Dermatol. 2012;167:1165-9.

114. Hanifin JM, Rajka G. Diagnosis features of atopic dermatitis. Acta Derm Venereol (Stockh). 1980; Suppl. 92:44-7.

115. Brenninkmeijer EE, Schram ME, Leeflang MM, Bos JD, Spuls PI. Diagnostic criteria for atopic dermatitis: a systematic review. The British journal of dermatology. 2008;158(4):754‑65.

116. Williams HC, Burney PG, Pembroke AC, Hay RJ. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol. 1994;131(3):406-16.

117. Kunz B, Oranje AP, Labrèze L, Stalder JF, Ring J, Taïeb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatol. 1997;195(1):10-9.

118. Oranje AP, Glazenburg EJ, Wolkerstorfer A, de Waard-van der Spek FB. Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score. Br J Dermatol. 2007;157(4):645-8.

119. Van Oosterhout M, Janmohamed SR, Spierings M, Hiddinga J, de Waard-van der Spek FB, Oranje AP. Correlation between Objective SCORAD and Three-Item Severity Score used by physicians and Objective PO-SCORAD used by parents/patients in children with atopic dermatitis. Dermatology. 2015;230(2):105-12.

120. Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol. 2001;10(1):11-8.

121. Schmitt J, Langan S, Deckert S, Svensson A, von Kobyletzki L, Thomas K, Spuls P. Harmonising Outcome Measures for Atopic Dermatitis (HOME) Initiative. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. J Allergy Clin Immunol. 2013;132(6):1337-47.

122. Flohr C, Johansson SGO, Wahlgren CF, Williams H. How atopic is atopic dermatitis? J Allergy Clin Immunol. 2004;114:150-8.

123. Werfel T, Allam JP, Biedermann T, Eyerich K, Gilles S, GuttmanYassky E, et al. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol. 2016;138:336-49.

124. Rossberg S, Gerhold K, Geske T, Zimmermann K, Menke G, Zaino M, et al. Elevated blood eosinophils in early infancy are predictive of atopic dermatitis in children with risk for atopy. Pediatr Allergy Immunol. 2016;27:702-8.

125. Kerkhof M, Dubois AE, Postma DS, Schouten JP, de Monchy JG. Role and interpretation of total serum IgE measurements in the diagnosis of allergic airway disease in adults. Allergy. 2003;58(9):905-11.

126. Laske N, Niggemann B. Does the severity of atopic dermatitis correlate with serum IgE levels? Pediatr Allergy Immunol. 2004;15(1):86-8.

127. Thijs J, Krastev T, Weidinger S, Buckens CF, de Bruin-Weller M, Bruijnzeel-Koomen C, et al. Biomarkers for atopic dermatitis: a systematic review and meta-analysis. Curr Opin Allergy Clin Immunol. 2015;15:453-60.

128. Kabashima-Kubo R, Nakamura M, Sakabe J, Sugita K, Hino R, Mori T, et al. A group of atopic dermatitis without IgE elevation or barrier impairment shows a high Th1 frequency: possible immunological state of the intrinsic type. J Dermatol Sci. 2012;67:37-43.

129. Lowe AJ, Carlin JB, Bennett CM, Hosking CS, Abramson MJ, Hill DJ, et al. Do boys do the atopic march while girls dawdle? J Allergy Clin Immunol. 2008;121:1190-5.

130. Heil PM, Maurer D, Klein B, Hultsch T, Stingl G. Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course - a randomized, placebo-controlled and double blind pilot study. J German Soc Dermatol. 2010; 8:990-98.

131. Kawamoto N, Fukao T, Kaneko H, Hirayama K, Sakurai S, Arai T, et al. Risk factors for infantile atopic dermatitis and recurrent wheezing. J Investig Allergol Clin Immunol. 2012;22:116-25.

132. Wen HJ, Wang YJ, Lin YC, Chang CC, Shieh CC, Lung FW, et al. Prediction of atopic dermatitis in 2-yr-old children by cord blood IgE, genetic polymorphisms in cytokine genes, and maternal mentality during pregnancy. Pediatr Allergy Immunol. 2011;22:695-703.

133. Chong Neto HJ, Rosário NA. Studying specific IgE: in vivo or in vitro. Allergol Immunopathol (Madr.). 2009;37:31-5.

134. Sampson HA, Albergo R. Comparison of results of skin tests, RAST and double-blind, placebo-controlled food challenges with atopic dermatitis. J Allergy Clin Immunol. 1984;74:26-33.

135. Lack G, Fox D, Northstone K, Golding J; Avon Longitudinal Study of Parents and Children Study Team. Factors associated with the development of peanut allergy in childhood. N Engl J Med. 2003;348(11):977-85.

136. Spergel JM, Boguniewicz M, Schneider L, Hanifin JM, Paller AS, Eichenfield LF. Food allergy in infants with atopic dermatitis: limitations of food-specific ige measurements. Pediatrics. 2015;136(6):e1530-8.

137. Tsakok T, Marrs T, Mohsin M, Baron S, du Toit G, Till S, et al. Does atopic dermatitis cause food allergy? A systematic review. J Allergy Clin Immunol. 2016;137(4):1071-8.

138. Hill DJ, Hosking CS, de Benedictis FM, Oranje AP, Diepgen TL, Bauchau V, et al. Confirmation of the association between high levels of immunoglobulin E food sensitization and eczema in infancy: an international study. Clin Exp Allergy. 2008;38(1):161-8.

139. Canonica GW, Ansotegui IJ, Pawankar R, Schmid-Grendelmeier P, van Hage M, Baena-Cagnani CE, et al. A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J. 2013;6(1):17.

140. Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, Valenta R, Hilger C, Hofmaier S, et al. EAACI Molecular Allergology User's Guide. Pediatr Allergy Immunol. 2016;27 Suppl 23:1-250.

141. Ott H, Fölster-Holst R, Merk HF, Baron JM. Allergen microarrays: a novel tool for high-resolution IgE profiling in adults with atopic dermatitis. Eur J Dermatol. 2010;20(1):54-61.

142. Gadisseur R, Chapelle JP, Cavalier E. A new tool in the field of in-vitro diagnosis of allergy: preliminary results in the comparison of ImmunoCAP© 250 with the ImmunoCAP© ISAC. Clin Chem Lab Med. 2011;49(2):277-80.

143. Kerschenlohr K, Darsow U, Burgdorf WH, Ring J, Wollenberg A. Lessons from atopy patch testing in atopic dermatitis. Cur Allergy Asthma Rep. 2004; 4:285-9.

144. Leung DY. Pathogenesis of atopic dermatitis. J Allergy Clin Immunol. 1999;104:S99-S108.

145. Leung DYM. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol. 2000;105:860‑76.

146. Beltani VS. The role of house dust mites and other aeroallergens in atopic dermatitis. Clin Dermatol. 2003;21:177-82.

147. Seidenari S, Giusti F, Pellacani G, Bertoni L. Frequency and intensity of responses to mite patch tests are lower in nonatopic subjects with respect to patients with atopic dermatitis. Allergy. 2003;58:426-9.

148. Resende ERMA, Segundo GRS. Testes cutâneos de leitura tardia para alimentos: revisão da literatura. Rev Bras Alerg Imunopatol. 2010; 33:184-9.

149. Giusti F. Reproducibility of atopy patch tests with Dermatophagoides: a study on 85 patients with atopic dermatitis. Contact Dermatitis. 2004;50:18-21.

150. Roehr CC, Reibel S, Ziegert M, Sommerfeld C, Wahn U, Niggemann B. Atopy patch tests, together with determination of specific IgE levels, reduce the need for oral food challenges in children with atopic dermatitis. J Allergy Clin Immunol. 2001;107:548-53.

151. Visitsunthorn N, Chatpornvorarux S, Pacharn P, Jirapongsananuruk O. Atopy patch test in children with atopic dermatitis. Ann Allergy Asthma Immunol. 2016;117:668-73.

152. Solé D, Silva LR, Rosário NA, Sarni ROS, Pastorino AC, Jacob CMA, et al. Consenso Brasileiro sobre Alergia Alimentar: 2007. Documento conjunto elaborado pela Sociedade Brasileira de Pediatria e Associação Brasileira de Alergia e Imunopatologia. Rev Bras Alerg Imunopatol. 2008;31(2):66-89.

153. Niggemann B. Role of oral food challenges in the diagnostic work-up of food allergy in atopic eczema dermatitis syndrome. Allergy. 2004;59:S32-4.

154. Werfel T, Ballmer-Weber B, Eigenmann PA, Niggemann B, Rancé F, Turjanmaa K, et al. Eczematous reactions to food in atopic eczema: position paper of the EAACI and GA2LEN. Allergy. 2007;62(7):723-8.

155. Bird JA, Lack G, Perry TT. Clinical management of food allergy. J Allergy Clin Immunol Pract. 2015;3(1):1-11.

156. Brand PL, Landzaat-Berghuizen MA. Differences between observers in interpreting double-blind placebo-controlled food challenges: a randomized trial. Pediatr Allergy Immunol. 2014;25(8):755-9.

157. Szabo I, Eigenmann PA. Allergenicity of major cow’s milk and peanut proteins determined by IgE and IgG immunoblotting. Allergy. 2000; 55:42-9.

158. Teuber SS, Porch-Curren C. Unproved diagnostic and therapeutic approaches to food allergy and intolerance. Curr Opin Allergy Clin Immunol. 2003; 3:217-21.

159. Erdmann SM, Heussen N, Moll-Siodowy S, Merk HF, Sachs B. CD63 expression on basophils as a tool for the diagnoses of pollen-associated food allergy: sensitivity and specificity. Clin Exp Allergy. 2003; 33:607-14.